H-like syndrome successfully treated with methotrexate

Dermatol Ther. 2019 Jul;32(4):e12994. doi: 10.1111/dth.12994. Epub 2019 Jun 25.

Authors

Anissa Zaouak¹, Hager Jaouadi², Amal Chamli³, Raja Jouini⁴, Sonia Abdelhak², Houda Hammami¹, Samy Fenniche¹

Affiliations

¹ Department of Dermatology, Research Unit "Genodermatoses and cancers" LR12SP03, Habib Thameur Hospital, Tunis, Tunisia.
² Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, Tunis, Tunisia.
³ Department of Dermatology, Habib Thameur Hospital, Tunis, Tunisia.
⁴ Department of Anatomopathology, Habib Thameur Hospital, Tunis, Tunisia.

PMID: 31197883
DOI: 10.1111/dth.12994

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Dermatologic Agents / therapeutic use*
Female
Humans
Hyperpigmentation / diagnosis
Hyperpigmentation / drug therapy
Hyperpigmentation / physiopathology
Methotrexate / therapeutic use*
Skin Diseases / diagnosis
Skin Diseases / drug therapy*
Skin Diseases / physiopathology
Syndrome

Substances

Dermatologic Agents
Methotrexate